Skip to content

European Journal of Neuroscience

ISSN 0953-816X, 1460-9568

63 papers in the library · 1,365 citations · publishing 1998-2026

Papers

Sort Most recent Most cited

Persistent cerebrovascular effects of MDMA and acute responses to the drug

European Journal of Neuroscience July 1, 2006 Linda Ferrington, Eszter Kirilly, Douglas E. Mcbean et al. 21 citations

Abstract Acutely, 3,4,‐methylenedioxymethamphetamine (MDMA) induces cerebrovascular dysfunction [ Quate et al ., (2004) Psychopharmacol. , 173 , 287–295]. In the longer term the same single dose results in depletion of 5‐hydroxytrptamine (5‐HT) nerve terminals. In this study we examined the cerebrovascular consequences of this persistent neurodegeneration, and the acute effects of subsequent...

MDMA and fenfluramine reduce L‐DOPA‐induced dyskinesia via indirect 5‐HT1A receptor stimulation

European Journal of Neuroscience May 1, 2006 Christopher Bishop, Jennifer L. Taylor, Donald M. Kuhn et al. 63 citations

Abstract Chronic l ‐3,4‐dihydroxyphenylalanine (L‐DOPA) pharmacotherapy in Parkinson's disease is often accompanied by the development of abnormal and excessive movements known as dyskinesia. Clinical and experimental studies indicate that indirect serotonin agonists can suppress dyskinesia without affecting the efficacy of L‐DOPA. While the mechanism by which these effects occur is not clear,...

Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons.

European Journal of Neuroscience May 2006 Anna Lisa Muntoni, Giuliano Pillolla, Miriam Melis et al.

The noradrenergic pathway arising from the locus coeruleus (LC) is involved in the regulation of attention, arousal, cognitive processes and sleep. These physiological activities are affected by Cannabis exposure - both in humans and laboratory animals. In addition, exogenous cannabinoids, as well as pharmacological and genetic manipulation of the endocannabinoid system, are known to influence...

Adenosine A2A receptors are involved in physical dependence and place conditioning induced by THC.

European Journal of Neuroscience October 2004 Guadalupe Soria, Anna Castañé, Fernando Berrendero et al.

A2A adenosine and CB1 cannabinoid receptors are highly expressed in the central nervous system, where they modulate numerous physiological processes including adaptive responses to drugs of abuse. Both purinergic and cannabinoid systems interact with dopamine neurotransmission (through A2A and CB1 receptors, respectively). Changes in dopamine neurotransmission play an important role in...

Prolonged cannabinoid treatment results in spatial working memory deficits and impaired long-term potentiation in the CA1 region of the hippocampus in vivo.

European Journal of Neuroscience August 2004 Matthew N Hill, David J Froc, Christopher J Fox et al.

Adult male Long-Evans rats were administered the potent cannabinoid 1 receptor agonist HU-210 (100 microg/kg, i.p.) for 15 days continuously and their performance on a matching-to-place version of the Morris water maze was subsequently evaluated. Overall, experimental animals performed significantly worse initially on the reference memory component of this task, but their performance improved...

The rewarding properties of MDMA are preserved in mice lacking µ‐opioid receptors

European Journal of Neuroscience July 15, 2004 Patricia Robledo, Victoria Mendizábal, Jordi Ortuño et al. 40 citations

Abstract The involvement of µ‐opioid receptors in the rewarding properties of MDMA was explored in µ‐opioid receptor knockout mice using the conditioning place preference paradigm. The associated release of dopamine in the nucleus accumbens was investigated by in vivo microdialysis. A significant rewarding effect of MDMA (10 mg/kg, i.p.) was observed in both wild‐type and µ‐opioid receptor...

DOI: 10.1111/j.1460-9568.2004.03532.x (opens in new tab) MDMA Nucleus accumbens Conditioned place preference Dopaminergic +6

Brain hyperthermia induced by MDMA (‘ecstasy’): modulation by environmental conditions

European Journal of Neuroscience July 1, 2004 Paul Brown, Eugene A. Kiyatkin 105 citations

Abstract Drugs of abuse, such as 3,4‐methylenedioxymethamphetamine (MDMA), often have more powerful effects during states of increased activation and under specific environmental conditions. Because hyperthermia is a major complication of MDMA use and a factor potentiating neurotoxicity, we examined the effects of this drug (9 mg/kg, sc; approximately one‐fifth of the known LD 50 in rats) on...

Methylenendioxyamphetamine produces serotonin nerve terminal loss and diminished behavioural and neurochemical responses to the antidepressant fluoxetine.

European Journal of Neuroscience August 2003 Andrew Harkin, Eamonn Shanahan, John P Kelly et al.

The effect of prior exposure to methylenedioxyamphetamine (MDA) on behavioural and neurochemical responses to fluoxetine were assessed in a rat model of antidepressant action. MDA (7.5 mg/kg, i.p.) was administered to rats twice daily for 4 consecutive days, and 4 weeks later the behavioural effect of fluoxetine (5 or 20 mg/kg; i.p. x 3) was examined in the modified rat forced-swimming test. In...

Neural correlates of religious experience.

European Journal of Neuroscience April 1, 2001 N P Azari, J Nickel, G Wunderlich et al.

The commonsense view of religious experience is that it is a preconceptual, immediate affective event. Work in philosophy and psychology, however, suggest that religious experience is an attributional cognitive phenomenon. Here the neural correlates of a religious experience are investigated using functional neuroimaging. During religious recitation, self-identified religious subjects activated...

Differential role of the nitric oxide pathway on delta(9)-THC-induced central nervous system effects in the mouse.

European Journal of Neuroscience February 2001 S C Azad, Giovanni Marsicano, I Eberlein et al.

This study investigated whether the nitric oxide pathway was involved in the central effects of Delta(9)-tetrahydrocannabinol (Delta(9)-THC), the major psychoactive constituent of cannabis sativa. Body temperature, nociception and locomotion were measured in neuronal nitric oxide synthase (nNOS) knock-out (KO) mice and wild-type (WT) controls after intraperitoneal application of Delta(9)-THC....

MDMA (‘ecstasy’) enhances basal acetylcholine release in brain slices of the rat striatum

European Journal of Neuroscience April 1, 2000 H. S. Fischer, Gerald Zernig, Dieter S. Schatz et al. 54 citations

Abstract The pharmacological basis of acute (±)‐MDMA (3,4‐methylenedioxymethamphetamine) intoxication still awaits full characterization. According to present knowledge, MDMA enhances the release of serotonin and dopamine in striatal slices and interacts with different types of receptors such as 5‐HT 2 (5‐hydroxytryptamine or serotonin), M 1 and M 2 muscarinic acetylcholine (ACh), and histamine...

DOI: 10.1046/j.1460-9568.2000.00004.x (opens in new tab) MDMA Serotonin Dopamine Muscarinic acetylcholine receptor +8

LSD and DOB: interaction with 5‐HT2A receptors to inhibit NMDA receptor‐mediated transmission in the rat prefrontal cortex

European Journal of Neuroscience September 1, 1999 Viktor L. Arvanov, Xiaofu Liang, Angelo Russo et al. 64 citations

Abstract Both the phenethylamine hallucinogen (–)‐1‐2,5‐dimethoxy‐4‐bromophenyl‐2‐aminopropane (DOB), a selective serotonin 5‐HT 2A,2C receptor agonist, and the indoleamine hallucinogen d ‐lysergic acid diethylamide (LSD, which binds to 5‐HT1A, 1B, 1D, 1E, 1F, 2A, 2C, 5, 6, 7, dopamine D 1 and D 2 , and α 1 and α 2 adrenergic receptors), but not their non‐hallucinogenic congeners, inhibited...

DOI: 10.1046/j.1460-9568.1999.00726.x (opens in new tab) Serotonin Hallucinogen Nmda receptor Pharmacology +8

Psychotomimetic-induction of tissue plasminogen activator mRNA in corticostriatal neurons in rat brain.

European Journal of Neuroscience November 1998 T Hashimoto, Y Kajii, T Nishikawa

We have studied in the rat the effects of acute subcutaneous injection of psychotomimetics including methamphetamine (MAP), cocaine and phencyclidine (PCP) on the expression of a brain plasticity-related molecule, tissue plasminogen activator (tPA) mRNA, using non-radioactive in situ hybridization histochemistry. In addition to the constitutive expression of tPA mRNA in cerebellar Purkinje...